Bayer reported 32.58B in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Akzo Nobel AKZA:NA 5.35B 205M
Alcon AG ALC:SW 5.39B 96M
Arkema AKE:FP € 5385M 136M
AstraZeneca AZN:LN 26.24B 447M
BASF BAS:GR 34.52B 1.4B
Bayer BAYN:GR 32.58B 633M
Covestro 1COV:GR 6.96B 208M
Fresenius FRE:GR € 17461M 127M
Genmab GEN:DC 23.18B 439M
Givaudan GIVN:VX 3.41B 200M
GRIFOLS GRF:SM € 3239.5M 153.93M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Johnson Matthey JMAT:LN 4.79B 83M
Linde LIN:GR 10.16B 1.85B
Lonza Group LONN:SW 5.96B 925M
Novartis NOVN:VX 45.72B 19.46B
SAP SAP:GR 20.04B 3.11B
Solvay SOLB:BB € 6833M 255M
Umicore UMI:BB 5.94B 437.6M